Atypical antipsychotic-induced mania/hypomania: a review of recent case reports and clinical studies

References

• Aubry JM, Simon AE, Bertschy G. Possible induction of mania and hypomania by olanzapine or risperidone: a critical review of reported cases. J Clin Psychiatry 2000;61:649–55.
   PubMed Web of Science ®Google Scholar
• Rachid F, Bertschy G, Bondolfi G, Aubry JM. Possible induction of mania or hypomania by atypical antipsychotics: an updated review of reported cases. J Clin Psychiatry 2004;65:1537–45.
   PubMed Web of Science ®Google Scholar
• Michalopoulou PG, Lykouras L. Manic/hypomanic symptoms induced by atypical antipsychotics: A review of the reported cases. Progress Neuro-Psychopharmacol Biol Psychiatry 2006;30:549–64.
   Google Scholar
• Brugue E, Vieta E. Atypical antipsychotics in bipolar depression: Neurobiological basis and clinical implications. Progress Neuro-Psychopharmacol Biol Psychiatry 2007;31(1):275–82.
   Google Scholar
• Vieta E, Calabrese JR, Goikolea JM, Raines S, Macfadden W, for the BSG. Quetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid-cycling disease course: a randomized, double-blind, placebo-controlled study. Bipolar Disord 2007;9(4):413–25.
   PubMedGoogle Scholar
• Thase ME, Macfadden W, Weisler RH CW, Paulsson B, Khan A, Calabrese JR; BOLDER II Study Group. Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study). J Clin Psychopharmacol 2006;26:600–9.
   PubMed Web of Science ®Google Scholar
• Calabrese JR, Keck PE Jr, Macfadden W, Minkwitz M, Ketter TA, Weisler RH, . A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry 2005;162:1351–60.
   PubMed Web of Science ®Google Scholar
• Keck PEJ, Corya SA, Altshuler LL, Ketter TA MS, Case M, Briggs SD, Tohen M. Analyses of treatment-emergent mania with olanzapine/fluoxetine combination in the treatment of bipolar depression. J Clin Psychiatry 2005;66:611–6.
   PubMed Web of Science ®Google Scholar
• Shelton RC, Stahl SM. Risperidone and paroxetine given singly and in combination for bipolar depression. J Clin Psychiatry 2004;65:1715–9.
   PubMed Web of Science ®Google Scholar
• Aggarwal A, Jain M, Khandelwal A, Jiloha RC. Amisulpride induced mania. Indian J Pharmacol 2010;42:112–3.
   Google Scholar
• Akdemir A, Türkçapar H, Örsel S. Mania and hypomania with olanzapine use. Eur Psychiatry 2004;19:175–6.
   Google Scholar
• Bakhla AK, Goyal N, Nizamie SH. Amisulpride-induced mania with interictal psychosis. Progress Neuro-Psychopharmacol Biol Psychiatry 2009;33:1572–3.
   Google Scholar
• Baldaçara L, de Castro Ferrari MC, Monteiro BF, Uchida RR, Sanches M. Hypomania induced by atypical antipsychotics among schizophrenic patients: report of three cases. Pharmacopsychiatry 2007;40:169–70.
   Google Scholar
• Barnas ME, Hussain N, Petrides G. Treatment-emergent psychosis with aripiprazole. J Clin Psychiatry 2005;66:1339.
   PubMed Web of Science ®Google Scholar
• Brieger P. Hypomanic episodes after receiving ziprasidone: an unintended “on-off-on” course of treatment. J Clin Psychiatry 2004;65:132–5.
   PubMed Web of Science ®Google Scholar
• Ducroix C, Beghelli F, Rousset I, Vacheron MN. Emergent mania with atypical antipsychotics: review of the literature about one case. Thérapie 2008;63:153–4.
   Google Scholar
• Erberk-Ozen N. Manic symptoms probably associated with short-term low-dose quetiapine use. Adv Ther 2008;25:53–8.
   Google Scholar
• Keating AM, Aoun SL, Dean CE. Ziprasidone-associated mania: a review and report of 2 additional cases. Clin Neuropharmacol 2005;28:83–6.
   PubMed Web of Science ®Google Scholar
• Liang CC, Chen JY, Chen TT, Bai YM. Zotepine-induced mania: two cases report. Eur Neuropsychopharmacol 2006;16(Suppl 4):S419–S.
   Google Scholar
• Mishra A, Moore PB, Hobbs R. Does quetiapine have mood altering properties? J Psychopharmacol 2004;18(2):281–4.
   Google Scholar
• Padala PR, Wengel SP, Petty F. Manic episode during treatment with aripiprazole. Am J Psychiatry 2007;164:172–3.
   Google Scholar
• Park YM, Lee SH, Lee HJ, Kim H, Lee KJ, Kang SG. Ziprasidone-associated mania in Korean schizophrenic patient. J Clin Psychopharmacol 2008;28:711–3.
   Google Scholar
• Traber R, Schneiter R, Modestin J. A case of aripiprazole-induced mania. Pharmacopsychiatry 2007;40:37–8.
   Google Scholar
• Wang WT, Chen CH, Lu M-L, Lai T-J. Paliperidone-induced mania-like symptoms: A case report. Progress Neuro-Psychopharmacol Biol Psychiatry 2010;34:1351–2.
   Google Scholar
• Yokoshima T, Takei N, Tani K, Kawai M, Minabe Y, Mori N. Two cases of perospirone-induced mania in schizophrenia. J Clin Psychiatry 2004;65:135.
   Google Scholar
• American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder. 2nd. Washington, DC: American Psychiatric Association; 2002 (DOI 101176/appibooks978089042336350051).
   Google Scholar
• Malhi GS, Adams D. Are guidelines in need of CPR? The development of clinical practice recommendations (CPR). Acta Psychiatr Scand 2009;Suppl 439:5–7.
   Google Scholar
• Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Möller HJ, . The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2009 on the Treatment of Acute Mania. World J Biol Psychiatry 2009; 10:85–116.
   PubMed Web of Science ®Google Scholar
• Yatham L. E.04.04 CANMAT/ISBD collaborative update of guidelines for bipolar disorder. Eur Neuropsychopharmacol 2009;19(Suppl 3):S222–S.
   Google Scholar
• Tatsumi M, Jansen K, Blakely RD, Richelson E. Pharmacological profile of neuroleptics at human monoamine transporters. Eur J Pharmacol 1999;368(2–3):277–83.
   PubMed Web of Science ®Google Scholar
• Nemeroff CB, Lieberman JA, Weiden PJ, Harvey PD, Newcomer JW, Schatzberg AF, . From clinical research to clinical practice: a 4-year review of ziprasidone. CNS Spectr 2005;10(11 Suppl 17):1–20.
   Google Scholar
• Vis PM, van Baardewijk M, Einarson TR. Duloxetine and venlafaxine-XR in the treatment of major depressive disorder: a meta-analysis of randomized clinical trials. Ann Pharmacother 2005;39(11):1798–807.
   Google Scholar
• Angst J. Switch from depression to mania — a record survey over decades between 1920 and 1982. Psychopathology 1985;18:140–54.
   PubMed Web of Science ®Google Scholar
• Ghaemi SN, Hsu DJ, Soldani F, Goodwin FK. Antidepressants in bipolar disorder: the case for caution. Bipolar Disord 2003;5:421–33.
   PubMed Web of Science ®Google Scholar
• Mundo E, Cattaneo E, Russo M, Altamura AC. Clinical variables related to antidepressant-induced mania in bipolar disorder. J Affect Disord 2006;92:227–30.
   PubMedGoogle Scholar
• Meltzer HY, Matsurbara S, Lee JC. The ratios of serotonin2 and dopamine2 affinities differentiate atypical and typical antipsychotic drugs. Psychopharmacol Bull 1989; 25:390–2.
   PubMed Web of Science ®Google Scholar
• Celada P, Puig MV, Amargós-Bosch M, Adell A, Artigas F. The therapeutic role of 5-HT1A and 5-HT2A receptors in depression. J Psychiatry Neurosci 2004;29:252–65.
   PubMed Web of Science ®Google Scholar
• Carlson T, Reynolds CA, Caplan R. Case report: valproic acid and risperidone treatment leading to development of hyperammonemia and mania. J Am Acad Child Adolesc Psychiatry 2007;46:356–61.
   Web of Science ®Google Scholar
• Thone J. Worsened agitation and confusion in schizophrenia subsequent to high-dose aripiprazole. J Neuropsychiatry Clin Neurosci 2007;19:481–2.
   PubMed Web of Science ®Google Scholar
• Reeves RR, Mack JE. Worsening schizoaffective disorder with aripiprazole. Am J Psychiatry 2004;161:1308.
   PubMed Web of Science ®Google Scholar